Aug. 2018 - "NanoLogix personnel and the CEO of the Biotechnology company have signed a mutual non-disclosure agreement limiting what can presently be revealed but once funding has been obtained and the study registered with the FDA and initiated, the identity of the pre-test development company should be available as public knowledge."

More than a year ago, obviously funding hasn't been obtained and the study hasn't been registered and initiated.....otherwise the identity would have been revealed.